Cargando…
Immune molecular profiling of a multiresistant primary prostate cancer with a neuroendocrine-like phenotype: a case report
BACKGROUND: Understanding the drivers of recurrence in aggressive prostate cancer requires detailed molecular and genomic understanding in order to aid therapeutic interventions. We provide here a case report of histological, transcriptional, proteomic, immunological, and genomic features in a longi...
Autores principales: | Williams, Scott G., Aw Yeang, Han Xian, Mitchell, Catherine, Caramia, Franco, Byrne, David J., Fox, Stephen B., Haupt, Sue, Schittenhelm, Ralf B., Neeson, Paul J., Haupt, Ygal, Keam, Simon P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592533/ https://www.ncbi.nlm.nih.gov/pubmed/33115461 http://dx.doi.org/10.1186/s12894-020-00738-8 |
Ejemplares similares
-
TP53 Status, Patient Sex, and the Immune Response as Determinants of Lung Cancer Patient Survival
por: Freudenstein, Donald, et al.
Publicado: (2020) -
High dose-rate brachytherapy of localized prostate cancer converts tumors from cold to hot
por: Keam, Simon P, et al.
Publicado: (2020) -
Establishing the Link between X-Chromosome Aberrations and TP53 Status, with Breast Cancer Patient Outcomes
por: Caramia, Franco, et al.
Publicado: (2023) -
P53: A Guardian of Immunity Becomes Its Saboteur through Mutation
por: Agupitan, Arjelle Decasa, et al.
Publicado: (2020) -
Modelling aggressive prostate cancers of young men in immune-competent mice, driven by isogenic Trp53 alterations and Pten loss
por: Mejía-Hernández, Javier Octavio, et al.
Publicado: (2022)